Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs JENBURKT PH. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA JENBURKT PH. SHUKRA PHARMA/
JENBURKT PH.
 
P/E (TTM) x 19.3 12.4 155.0% View Chart
P/BV x 14.1 2.5 568.4% View Chart
Dividend Yield % 0.2 2.1 7.3%  

Financials

 SHUKRA PHARMA   JENBURKT PH.
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
JENBURKT PH.
Mar-23
SHUKRA PHARMA/
JENBURKT PH.
5-Yr Chart
Click to enlarge
High Rs89760 11.7%   
Low Rs11452 2.5%   
Sales per share (Unadj.) Rs53.7310.1 17.3%  
Earnings per share (Unadj.) Rs4.055.8 7.2%  
Cash flow per share (Unadj.) Rs5.760.9 9.4%  
Dividends per share (Unadj.) Rs0.5014.40 3.5%  
Avg Dividend yield %1.02.4 42.2%  
Book value per share (Unadj.) Rs23.1277.5 8.3%  
Shares outstanding (eoy) m10.964.41 248.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.92.0 47.5%   
Avg P/E ratio x12.410.9 114.2%  
P/CF ratio (eoy) x8.810.0 88.0%  
Price / Book Value ratio x2.22.2 98.9%  
Dividend payout %12.425.8 48.1%   
Avg Mkt Cap Rs m5472,675 20.5%   
No. of employees `000NANA-   
Total wages/salary Rs m44388 11.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5881,367 43.0%  
Other income Rs m1251 23.4%   
Total revenues Rs m6001,419 42.3%   
Gross profit Rs m54304 17.7%  
Depreciation Rs m1823 81.4%   
Interest Rs m34 76.6%   
Profit before tax Rs m44329 13.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m083 0.4%   
Profit after tax Rs m44246 17.9%  
Gross profit margin %9.122.2 41.1%  
Effective tax rate %0.825.1 3.2%   
Net profit margin %7.518.0 41.6%  
BALANCE SHEET DATA
Current assets Rs m531811 65.4%   
Current liabilities Rs m425158 269.7%   
Net working cap to sales %18.047.8 37.6%  
Current ratio x1.25.1 24.3%  
Inventory Days Days0130 0.0%  
Debtors Days Days1,873453 413.7%  
Net fixed assets Rs m219603 36.3%   
Share capital Rs m3944 88.7%   
"Free" reserves Rs m2141,180 18.1%   
Net worth Rs m2531,224 20.7%   
Long term debt Rs m380-   
Total assets Rs m7501,414 53.0%  
Interest coverage x16.890.6 18.6%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.81.0 81.1%   
Return on assets %6.317.7 35.4%  
Return on equity %17.420.1 86.6%  
Return on capital %16.227.2 59.8%  
Exports to sales %018.5 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA253 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m0253 0.0%   
Fx outflow Rs m022 0.0%   
Net fx Rs m0231 0.0%   
CASH FLOW
From Operations Rs m32171 18.6%  
From Investments Rs m-4426 -169.1%  
From Financial Activity Rs m49-210 -23.5%  
Net Cashflow Rs m37-14 -268.7%  

Share Holding

Indian Promoters % 51.0 47.4 107.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 52.6 93.2%  
Shareholders   10,963 6,021 182.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RELISH PHARMA vs JENBURKT PH.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs JENBURKT PH. Share Price Performance

Period RELISH PHARMA JENBURKT PH. S&P BSE HEALTHCARE
1-Day -2.00% -1.37% 1.18%
1-Month 18.32% -12.42% -0.75%
1-Year 528.10% -0.35% 61.82%
3-Year CAGR 229.50% 20.40% 18.16%
5-Year CAGR 114.18% 6.85% 19.79%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the JENBURKT PH. share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of JENBURKT PH. the stake stands at 47.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of JENBURKT PH..

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 12.4%.

JENBURKT PH. paid Rs 14.4, and its dividend payout ratio stood at 25.8%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of JENBURKT PH..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.